This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Fluid and electrolyte disorders
  • /
  • Hyperkalemia in chronic kidney disease

Hyperkalemia in chronic kidney disease

Read time: 1 mins
Published:12th Jan 2020
Author: Watanabe R.
Availability: Free full text
Ref.:Rev Assoc Med Bras (1992). 2020 Jan 13;66Suppl 1(Suppl 1):s31-s36.
Hyperkalemia in chronic kidney disease

Hyperkalemia is a frequent finding in patients with chronic kidney disease (CKD). This increase in serum potassium levels is associated with decreased renal ion excretion, as well as the use of medications to reduce the progression of CKD or to control associated diseases such as diabetes mellitus and heart failure. Hyperkalemia increases the risk of cardiac arrhythmia episodes and sudden death. Thus, the control of potassium elevation is essential for reducing the mortality rate in this population. Initially, the management of hyperkalemia includes orientation of low potassium diets and monitoring of patients' adherence to this procedure. It is also important to know the medications in use and the presence of comorbidities to guide dose reduction or even temporary withdrawal of any of the potassium retention-related drugs. And finally, the use of potassium binders is indicated in both acute episodes and chronic hyperkalemia.

Read abstract on library site    Access full article